3095-47-4

Basic information

• Product Name: ethyl 4-aMino-3,5-diMethylbenzoate
• Synonyms: ethyl 4-aMino-3,5-diMethylbenzoate;Benzoic acid, 4-amino-3,5-dimethyl-, ethyl ester
• CAS NO: 3095-47-4
• Molecular Formula: C₁₁H₁₅NO₂
• Molecular Weight: 193.2423
• Mol File: 3095-47-4.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 343.9 °C at 760 mmHg
• Flash Point: 190.5 °C
• Appearance: /
• Density: 1.081 g/cm³
• Vapor Pressure: 6.83E-05mmHg at 25°C
• Refractive Index: 1.545
• CAS DataBase Reference: ethyl 4-aMino-3,5-diMethylbenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 4-aMino-3,5-diMethylbenzoate(3095-47-4)
• EPA Substance Registry System: ethyl 4-aMino-3,5-diMethylbenzoate(3095-47-4)

Safety Data

• Hazardous Substances Data: 3095-47-4(Hazardous Substances Data)

Usage

General Description

Ethyl 4-amin-3,5-dimethylbenzoate is a chemical compound with the molecular formula C13H17NO2. It is an ester derived from benzoic acid and ethanol, and it contains an amino group and two methyl groups attached to the benzene ring. ethyl 4-aMino-3,5-diMethylbenzoate is commonly used in the pharmaceutical industry as an intermediate in the synthesis of various drugs and pharmaceuticals. It is also known for its mild, sweet odor and is used as a fragrance ingredient in perfumes and cosmetic products. Additionally, it has been studied for its potential anti-inflammatory and antioxidant properties. Overall, ethyl 4-amin-3,5-dimethylbenzoate is a versatile chemical compound with applications in both the pharmaceutical and cosmetic industries.

InChI:InChI=1/C11H15NO2/c1-4-14-11(13)9-5-7(2)10(12)8(3)6-9/h5-6H,4,12H2,1-3H3

Upstream product

• 40800-65-5 1-amino-2-methylbenzene-4-carboxylic acid ethyl ester 
• 3095-50-9 3,5-dimethyl-4-nitrobenzoic acid ethyl ester 
• 3095-38-3 3,5-dimethyl-4-nitrobenzoic acid 

Downstream Products

• 1048677-10-6 ethyl 4-iodo-3,5-dimethylbenzoate 
• 115976-71-1 3,5-dimethyl-4-phenylazobenzoic acid ethyl ester 
• 87-62-7 2,6-dimethylaniline 
• 1621681-39-7 ethyl 4-(5-bromo-2-chlorobenzamido)-3,5-dimethylbenzoate 
• 1621681-31-9 4-(2-chloro-5-isobutoxy-N-methylbenzamido)-3,5-dimethylbenzoic acid 
• 1621680-68-9 4-(4-chloro-3'-methoxybiphenyl-3-ylcarboxamido)-3,5-dimethylbenzoic acid 
• 1621680-91-8 4-(2-chloro-5-isobutoxybenzamido)-3,5-dimethylbenzoic acid 
• 1621681-50-2 ethyl 4-(4-chloro-3'-methoxybiphenyl-3-ylcarboxamido)-3,5-dimethylbenzoate 

Relevant articles and documents

Nainai non-west tanzania intermediate 2, 6 - dimethyl aniline synthesis method

The invention discloses a nainai non-west tanzania intermediate 2 - pyrrolidone synthetic method, the 4 - amino - 3 - methyl benzoate with halogenated methane under the effects of catalyst obtained by reaction of 2, 6 - dimethyl aniline, the 4 - amino - 3 - methyl benzoate, protective agent and solvent A reaction mixture obtained from I; halogenated methane, catalyst and solvent B mixing, then mixing the mixture I II into the reaction mixture; adding an aqueous solution of hydrochloric acid in the reaction mixture is mixed with the mixture II III; III will be alkali water dripped into the mixture, the reaction mixture obtained from IV; the mixture is poured into the IV 3 - 4 times of the volume of water, added with a solvent extracting C, layered, organic layer after the water washing, after drying agent, concentrated evaporate the solvent to obtain the product. The method of low cost, high yield, blowdown less.

SUBSTITUTED BENZAMIDES WITH ACTIVITY TOWARDS EP4 RECEPTORS

The present invention belongs to the field of EP4 receptor ligands. More specifically it refers to compounds of general formula (I) having great affinity and selectivity for the EP4 receptor. The invention also refers to the process for their preparation, to their use as medicament for the treatment and/or prophylaxis of diseases or disorders mediated by the EP4 receptor as well as to pharmaceutical compositions comprising them.

Novel opioid peptide derived antagonists containing (2S)-2-methyl-3-(2,6- dimethyl-4-carbamoylphenyl)propanoic acid [(2S)-Mdcp]

A synthesis of the novel tyrosine analogue (2S)-2-methyl-3-(2,6-dimethyl-4- carbamoylphenyl)propanoic acid [(2S)-Mdcp] (15) was developed. In (2S)-Mdcp, the amino and hydroxyl groups of 2′,6′-dimethyltyrosine are replaced by a methyl and a carbamoyl group